References
- Khan SR. Heterogeneous nucleation of calcium oxalate mammalian urine. Scanning Microsc 1995;9: crystals in 597–616.
- Khan SR. Calcium phosphate/calcium oxalate crystal asso-urinary stones: implications for heterogeneous of calcium oxalate. J Urol 1997;157:376-83.ciation in nucleation
- Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG. Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macro-molecules. Urol Res 1999;27:417–25.
- Khan SR, Glenton PA, Backov R, Talham DR. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney hit 2002;62:2062–72.
- Egan TJ, Rodgers AL, Siele T. Nucleation of calcium oxalate crystals on an imprinted polymer surface from pure aqueous solution and urine. J Biol Inorg Chem 2004;9:195–202.
- Lieske JC, Toback FG, Deganello S. Direct nucleation of calcium oxalate dihydrate crystals onto the surface of living renal epithelial cells in culture. Kidney Int 1998;54:796–803.
- Fasano JM, Khan SR. Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney hit 2001;59:169–78.
- Marangella M, Bagnis C, Bruno M, Vitale C, Petrarulo M, Ramello A. Crystallization inhibitors in the pathophysiology and treatment of nephrolithiasis. Urol hit 2004;72:6–10.
- Senzaki H, Yasui T, Okada A, Ito Y, Tozawa K, Kohri K. Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model. Urol Res 2004;32:223–8.
- Worcester EM. Inhibitors of stone formation. Semin Ne-phrol 1996;16:474–86.
- Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney hit 1997;51:640–5.
- Wesson JA, Worcester EM, Wiessner JH, Mandel NS, Kleinman JG. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney hit 1998;53:952–7.
- Dussol B, Berland Y. Urinary kidney stone inhibitors. What is the news? Urol Int 1998;60:69–73.
- Ebisuno S, Nishihata M, Inagaki T, Umehara M, Kohjimoto Y. Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine. J Am Soc Nephrol 1999; 10:S436–40.
- Grases F, Garcia-Ferragut L, Costa-Bauth A. Analytical study of renal calculi. A new insight. Recent Results Dev Pure Appl Anal Chem 1998;1:187–206.
- Grases F, March JG, Prieto RM, Simonet BM, Costa-Bauzá A, Garcia-Raja A, et al. Urinary phytate in calcium oxalate stone formers and healthy people. Scand J Urol Nephrol 2000;34:162–4.
- Rutsch F, Schauerte P, Kalhoff H, Petrarulo M, August C, Diekmann L. Low levels of urinary inorganic pyrophosphate indicating systemic pyrophosphate deficiency in a boy with idiopathic infantile arterial calcification. Acta Pediatr 2000;89:1265–9.
- March JG, Simonet BM, Grases F. Determination of pyrophosphate in renal calculi and urine by means of an enzymatic method. Chin Chim Acta 2001;314:187–94.
- Roberts NB, Dutton J, Helliwell T, Rothwell PJ, Kavanagh JP. Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease. Ann Chin Biochem 1992;29:529–34.
- Siener R, Jahnen A, Hesse A. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Chin Nutr 2004;58:270–6.
- Kato Y, Yamaguchi S, Yachiku S, Nakazono S, Hon J, Wada N, et al. Changes in urinary parameters after oral adminis-tration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urology 2004;63:7–12.
- Grases F, Costa-Bauzá A, Ramis M, Montesinos V, Conte A. Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta 2002;322: 29–36.
- Berland Y. Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches. Nephrologie 1999;20:363–9.
- Grases F, Costa-Bauzá A, Garcia-Ferragut L. Biopathologi-cal crystallization: a general view about the mechanisms of renal stone formation. Adv Colloid Interface Sci 1998;74: 169–94.
- Peacock M. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 2002;17:N87–94.
- Bushinsky DA, Parker WR, Asplin JR. Calcium phosphate supersaturation regulates stone formation in genetic hyper-calciuric stone-forming rats. Kidney Int 2000;57:550–60.
- Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, et al. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine (Baltimore) 1991;70:345–59.
- Grases F, Simonet BM, Prieto RM, March JG. Phytate levels in diverse rat tissues: influence of dietary phytate. Br J Nutr 2001;86:225–31.
- Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: nurses' health study II. Arch Intern Med 2004;164: 885–91.
- Grases F, Milian A, Conte A. Production of calcium oxalate monohydrate, dihydrate or trihydrate. Urol Res 1990;18: 17–20.
- Normand M, Bergua D, Bouvet JP, Cayotte JL, Gottis M. Correlation of the cause and composition of renal calculi. Value of morphologic and infrared analysis. Ann Biol Chin 1989;47:29–34.